Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
Ann Nucl Med
    September 2026
  1. ZIRAKCHIAN ZADEH M
    Is It time to move beyond FDG toward a more specific yet broadly applicable radiotracer such as FAPI? why yes-and why not.
    Ann Nucl Med. 2026;40:1031-1042.
    >> Share

    August 2026
  2. ALBANO D, Jiang C, Bertagna F
    [(18)F]FDG PET/CT role in FUO among patients with end-stage renal disease on renal replacement therapy.
    Ann Nucl Med. 2026 Aug 27. doi: 10.1007/s12149-026-02277.
    >> Share

  3. KOJITA Y, Ishii K, Yamada T, Hanaoka K, et al
    Regional differences in (18)F-flutemetamol accumulation between amyloid-positive and -negative brains using high-resolution dedicated head PET scanner.
    Ann Nucl Med. 2026 Aug 26. doi: 10.1007/s12149-026-02272.
    >> Share

  4. OKAR Y, Sahin OF, Erhamamci S, Atik DY, et al
    Baseline (18)F-FDG PET/CT-derived heterogeneity index predicts poor pathological response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Ann Nucl Med. 2026 Aug 21. doi: 10.1007/s12149-026-02270.
    >> Share

    July 2026
  5. METWALLY HK, Gawaad HA, Khalil MM
    Differential performance of statistical versus machine learning methods in partial volume correction in oncologic F18-FDG PET/CT scanning.
    Ann Nucl Med. 2026 Jul 31. doi: 10.1007/s12149-026-02255.
    >> Share

  6. KITAMURA T, Kawaguchi N, Matsuoka M, Matsumoto K, et al
    Clinical significance of suspicious incidental FDG uptake: a comparison between digital PET/CT and conventional PET/CT.
    Ann Nucl Med. 2026 Jul 24. doi: 10.1007/s12149-026-02264.
    >> Share

  7. TAKAHASHI M, Pairodsantikul P, Watabe H, Shidahara M, et al
    Impact of posture change on patient-specific absorbed dose estimation in nuclear medicine.
    Ann Nucl Med. 2026 Jul 23. doi: 10.1007/s12149-026-02263.
    >> Share

  8. SEKER K, Yilmaz M, Erdis E, Hasbek Z, et al
    Development of a (18)F-FDG PET/CT-based radiomic risk score as an independent prognostic factor in small cell lung cancer.
    Ann Nucl Med. 2026 Jul 20. doi: 10.1007/s12149-026-02261.
    >> Share

  9. IMABAYASHI E, Morris A, Iaccarino L, Arora AK, et al
    (18)F-flortaucipir PET imaging: Biodistribution in the Japanese population and diagnostic accuracy by Japanese readers.
    Ann Nucl Med. 2026 Jul 17. doi: 10.1007/s12149-026-02239.
    >> Share

  10. RIBEIRO AMB, Rinck JA Jr, de Cassio Zequi S
    Prospective evaluation of (18)F-PSMA-1007 PET/CT in renal masses paired with PSMA immunohistochemistry.
    Ann Nucl Med. 2026 Jul 13. doi: 10.1007/s12149-026-02259.
    >> Share

  11. FURUYA Y, Tsujimoto M, Asai T, Iwama I, et al
    Quantitative SPECT imaging for predicting therapeutic response to lutetium-177 DOTATATE in neuroendocrine tumors.
    Ann Nucl Med. 2026 Jul 11. doi: 10.1007/s12149-026-02256.
    >> Share

  12. OVUT AR, Toyran R, Bulbul NG, Urhan M, et al
    A real-world decision tree model based on (1)(8)F-FDG PET/CT Z scores and Mini-Mental State Examination for differentiating mild cognitive impairment from clinically diagnosed Alzheimer disease.
    Ann Nucl Med. 2026 Jul 9. doi: 10.1007/s12149-026-02257.
    >> Share

  13. CHEN X, Peng Y, Zheng Q, Lai Y, et al
    The Prognostic Value of (68)Ga-PSMA and (18)F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with (177)Lu-EB-PSMA.
    Ann Nucl Med. 2026 Jul 1. doi: 10.1007/s12149-026-02250.
    >> Share

    June 2026
  14. TOMIYAMA A, Iwabuchi Y, Tonda K, Owaki Y, et al
    Impact of biguanide therapy on hepatic (18)F-fluorodeoxyglucose-positron emission tomography quantitative parameters in patients with diabetes: a dynamic positron emission tomography study.
    Ann Nucl Med. 2026 Jun 29. doi: 10.1007/s12149-026-02251.
    >> Share

  15. PALA H, Tuncel M, Yalcin S, Karabulut E, et al
    Dual-time-point 68Ga-FAPI PET/CT in gastrointestinal malignancies: head-to-head comparison with 18 F-FDG for lesion detection and patient-level assessment.
    Ann Nucl Med. 2026 Jun 25. doi: 10.1007/s12149-026-02249.
    >> Share

  16. GAMBIEZ M, David E, Leplont C, Buee CL, et al
    Bloodpool SPECT/CT offers enhanced sensitivity for the diagnosis of frozen shoulder.
    Ann Nucl Med. 2026 Jun 20. doi: 10.1007/s12149-026-02246.
    >> Share

  17. NAOI J, Takanami K, Kiso K, Shidahara M, et al
    Detection ability of model observer for diagnosis of active cardiac sarcoidosis on (18)F-FDG-PET.
    Ann Nucl Med. 2026 Jun 15. doi: 10.1007/s12149-026-02248.
    >> Share

  18. YAMAO T, Miwa K, Hasegawa K, Miyaji N, et al
    Straightforward PET phantom preparation using (68)Gallium diluted with acid.
    Ann Nucl Med. 2026 Jun 9. doi: 10.1007/s12149-026-02245.
    >> Share

  19. CUI Y, Wang M, Liu Y, Liu Y, et al
    Local aggressiveness and prognostic prediction in desmoid-type fibromatosis: insights from (18)F-FDG PET/CT.
    Ann Nucl Med. 2026 Jun 1. doi: 10.1007/s12149-026-02221.
    >> Share

  20. TSUSHIMA F, Koshiishi T, Shintaku T, Maruyama S, et al
    Utility of preoperative [(1)(8)F]FDG PET/CT for CT-guided biopsy polanning of large tumors: target adjustment and malignant yield with hotspot targeting.
    Ann Nucl Med. 2026 Jun 1. doi: 10.1007/s12149-026-02242.
    >> Share

    May 2026
  21. OZBEK RD, Aytekin A, Yerdes E, Elboga U, et al
    The role of 18 F-FDG PET/CT SUVmax values in evaluating treatment response in hormone receptor-positive metastatic breast cancer patients receiving CDK4/6 inhibitor therapy.
    Ann Nucl Med. 2026 May 29. doi: 10.1007/s12149-026-02233.
    >> Share

  22. LOMER NB, Sadeghpour S, Torigian DA
    FDG-PET/CT Parameters for distinguishing high and low microsatellite instability in colorectal cancer: A systematic review and Meta-analysis.
    Ann Nucl Med. 2026 May 29. doi: 10.1007/s12149-026-02240.
    >> Share

  23. OZKAN E, Demir B, Cengiz Seval G, Araz M, et al
    Response to the comment on "[11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma".
    Ann Nucl Med. 2026 May 25. doi: 10.1007/s12149-026-02237.
    >> Share

  24. HANAFY MM, Kamal RM, Khater SHSA, Kirollus MMG, et al
    Patterns of positron emission mammography uptake by benign and malignant breast lesions: radiopathological correlation with malignant histopathological subtypes, histological grades, and molecular subtypes.
    Ann Nucl Med. 2026 May 25. doi: 10.1007/s12149-026-02234.
    >> Share

  25. MERCIER B, Dreano L, Neveu E, Estrade F, et al
    Baseline PSMA-ligand PET/CT as a predictive biomarker for early progression in metastatic castration-resistant prostate cancer patients undergoing [177Lu]Lu-PSMA-617 radioligand therapy.
    Ann Nucl Med. 2026 May 23. doi: 10.1007/s12149-026-02236.
    >> Share

  26. ERDOGAN M, Korkmaz H, Avci M, Ozdemir Z, et al
    Early clinical experience with (6)(8)Ga-Trivehexin PET/CT in parathyroid adenomas: a proof-of- concept imaging study.
    Ann Nucl Med. 2026 May 22. doi: 10.1007/s12149-026-02232.
    >> Share

  27. SOYDAS-TURAN B, Volkan-Salanci B, Aydin B, Kiratli P, et al
    18 F-FDG PET/CT Derived Volumetric Parameters Can Predict Outcome in Pediatric Ewing Sarcoma.
    Ann Nucl Med. 2026 May 21. doi: 10.1007/s12149-026-02229.
    >> Share

  28. LIN YC, Chang CC, Yeh TJ, Hsieh TY, et al
    Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphoma.
    Ann Nucl Med. 2026 May 20. doi: 10.1007/s12149-026-02230.
    >> Share

  29. USMANI S, Hashmi SF, Jain A, Al Saifi S, et al
    Integration of (6)(8)Ga-DOTA-TOC PET/CT into radiotherapy planning for intracranial meningiomas: A precision-imaging approach to tumor delineation.
    Ann Nucl Med. 2026 May 19. doi: 10.1007/s12149-026-02226.
    >> Share

  30. YAMAKUNI R, Seino S, Yamaki A, Shima A, et al
    Whole-brain histogram analysis and top 20% gray and white matter ratio of amyloid positron emission tomography: A comparison with the centiloid scale.
    Ann Nucl Med. 2026 May 18. doi: 10.1007/s12149-026-02218.
    >> Share

  31. CHIARAVALLOTI A, Egidi M, D'Agostini A, Filippi L, et al
    Semiquantitative SSTR PET metrics show molecular-morphologic discordance after 177Lu-DOTATATE in gastroenteropancreatic neuroendocrine neoplasms: an exploratory paired target-lesion analysis.
    Ann Nucl Med. 2026 May 18. doi: 10.1007/s12149-026-02231.
    >> Share

  32. GUZEL F, Komek H, Alan N, Can C, et al
    Beyond conventional maging: the diagnostic performance of [(68)Ga]Ga-Trivehexin PET/CT for detecting hyperfunctioning parathyroid tissue in primary hyperparathyroidism.
    Ann Nucl Med. 2026 May 11. doi: 10.1007/s12149-026-02220.
    >> Share

  33. SHIIBA T, Azuma H, Maeda K, Tanahashi S, et al
    Phantom-based optimization of [(18)F]fluciclovine neuro-oncology imaging on a high-resolution dedicated head PET system: dual-pathway reconstruction protocols.
    Ann Nucl Med. 2026 May 11. doi: 10.1007/s12149-026-02224.
    >> Share

  34. MANABE O, Watanabe S, Hirata K, Aikawa T, et al
    Interpretation of myocardial FDG uptake during corticosteroid therapy in cardiac sarcoidosis evaluation with (18)F-FDG PET/CT.
    Ann Nucl Med. 2026 May 11. doi: 10.1007/s12149-026-02222.
    >> Share

  35. NOGAMI M, Matsuo H, Nishio M, Zeng F, et al
    Zero-TE MRI-based attenuation correction for bone components on chest [(18)F] FDG PET/MRI: accuracy, repeatability, and external validation of an unsupervised deep learning approach using unpaired PET/CT data.
    Ann Nucl Med. 2026 May 9. doi: 10.1007/s12149-026-02213.
    >> Share

  36. KAWAKUBO M, Kaimoto Y, Yamamoto A, Watanabe M, et al
    Myocardial flow reserve estimation from standardized uptake values of (13)N-ammonia imaging with a silicon photomultiplier positron emission tomography/computed tomography system.
    Ann Nucl Med. 2026 May 8. doi: 10.1007/s12149-026-02219.
    >> Share

  37. SANTO G, Rosarno H, Restuccia A, Cascini GL, et al
    Biochemical failure after radical prostatectomy with PSA
    Ann Nucl Med. 2026;40:521-531.
    >> Share

  38. YAMAKUNI R, Ukon N, Kanezawa T, Ishikawa H, et al
    Effect of magnetic resonance image-based motion correction on the centiloid scale: a comparison with and without correction.
    Ann Nucl Med. 2026;40:552-563.
    >> Share

  39. WATANABE S, Hirata K, Takenaka J, Munakata Y, et al
    Somatostatin receptor expression for peptide receptor radionuclide therapy in Japanese patients with recurrent or metastatic differentiated thyroid cancer.
    Ann Nucl Med. 2026;40:539-551.
    >> Share

    April 2026
  40. MAHFOUZ RA, Mohammad MG, Ouf SG, Zidan ASA, et al
    Coronary microvascular injury detection and prediction after successful primary percutaneous coronary intervention: non-invasive assessment using single photon emission tomography myocardial perfusion imaging.
    Ann Nucl Med. 2026 Apr 27. doi: 10.1007/s12149-026-02208.
    >> Share

  41. SHIMIZU K, Matsumoto K, Omasa W, Akamatsu G, et al
    Error analysis of cerebral blood flow and oxygen metabolism in three-dimensional (15)O-gas positron emission tomography acquisition.
    Ann Nucl Med. 2026 Apr 27. doi: 10.1007/s12149-026-02217.
    >> Share

  42. HIRAOKA K
    Response to the comment on "Kinetic and quantitative analysis of [(18)F]SMBT-1 PET imaging for monoamine oxidase B".
    Ann Nucl Med. 2026 Apr 19. doi: 10.1007/s12149-026-02214.
    >> Share

  43. SONG Q, Li M
    Letter to the editor: [(18)F]SMBT-1 PET quantification - methodological considerations and future directions.
    Ann Nucl Med. 2026 Apr 17. doi: 10.1007/s12149-026-02203.
    >> Share

  44. TAKAHASHI K, Yamamoto S, Sasaki D, Iwamura T, et al
    Visceral technetium-99 m-labeled pyrophosphate uptake in patients with wild-type transthyretin cardiac amyloidosis.
    Ann Nucl Med. 2026 Apr 16. doi: 10.1007/s12149-026-02174.
    >> Share

  45. EL BARKAOUI AE, Scheiber C, Thobois S, Buchert R, et al
    Performance of CT-guided spatial normalization for semi-quantification of dopamine transporter SPECT and detection of nigrostriatal degeneration.
    Ann Nucl Med. 2026 Apr 13. doi: 10.1007/s12149-026-02204.
    >> Share

  46. IBRAHIM EA
    PSMA PET/CT imaging for biochemical recurrence in prostate cancer: can it replace conventional imaging and guide salvage therapy?
    Ann Nucl Med. 2026 Apr 13. doi: 10.1007/s12149-026-02192.
    >> Share

  47. RUAN T
    The 68Ga-PSMA-11 PET/CT PRIMARY score for predicting pathological upgrading in ISUP grade group 1 prostate cancer: Methodological considerations and future directions.
    Ann Nucl Med. 2026 Apr 11. doi: 10.1007/s12149-026-02207.
    >> Share

  48. NAKAMOTO Y, Tatsumi M, Nishii R, Kato K, et al
    A narrative review: key evidence from meta-analyses in nuclear medicine.
    Ann Nucl Med. 2026 Apr 7. doi: 10.1007/s12149-026-02201.
    >> Share

  49. DEMIR B, Hosgoren Alici Y, Araz M, Dursun Avci E, et al
    Impact of shortened dynamic PET/MR protocols on D(1) receptor quantification with [(11)C]?NNC112.
    Ann Nucl Med. 2026 Apr 7. doi: 10.1007/s12149-026-02202.
    >> Share

  50. KITANO Y, Miyake KK, Nobashi TW, Ishimori T, et al
    Response to the comment on "Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and (1)(8)F-FDG PET/CT".
    Ann Nucl Med. 2026 Apr 2. doi: 10.1007/s12149-026-02177.
    >> Share

  51. BOSQUE JJ, Molina-Garcia D, Perez-Beteta J, Vicente AMG, et al
    Complementary prognostic value of hotspot-to-centroid distance (NHOCpeak) to SUVpeak in high-grade glioma.
    Ann Nucl Med. 2026;40:373-383.
    >> Share

    March 2026
  52. GAMBIEZ M, Palard-Novello X, Guery C, Marchal E, et al
    Multicenter evaluation of commercial AI for [(18)F]FDG PET/CT lesion detection.
    Ann Nucl Med. 2026 Mar 30. doi: 10.1007/s12149-026-02199.
    >> Share

  53. KESKIN M
    Adenosine FDG PET/CT reveals potentially viable myocardium in ischemic cardiomyopathy.
    Ann Nucl Med. 2026 Mar 27. doi: 10.1007/s12149-026-02196.
    >> Share

  54. VALSAMAKI PN, Tsakaldimis G
    Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight?
    Ann Nucl Med. 2026 Mar 26. doi: 10.1007/s12149-026-02195.
    >> Share

  55. TSOUGOS I, Valotassiou V, Tsivaka D, Satra M, et al
    SPECT and PET imaging of Alzheimer's disease revisited: from biomarkers to artificial intelligence-based prediction.
    Ann Nucl Med. 2026 Mar 26. doi: 10.1007/s12149-026-02194.
    >> Share

  56. CAGDAS B, Cagdas EK, Yuksel AO, San H, et al
    Lesion-level quantitative Lu-177 PSMA SPECT/CT SUV metrics are associated with interim treatment response in mCRPC: a PET-correlated study.
    Ann Nucl Med. 2026 Mar 18. doi: 10.1007/s12149-026-02193.
    >> Share

  57. WU P, Hao K, Li Y, Wang Y, et al
    The diagnostic and therapeutic value of FDG PET/CT for infectious diseases in FUO/IUO patients.
    Ann Nucl Med. 2026 Mar 16. doi: 10.1007/s12149-026-02190.
    >> Share

  58. KITANO Y, Miyake KK, Nobashi TW, Ishimori T, et al
    Correction: Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and (1)(8)F-FDG PET/CT.
    Ann Nucl Med. 2026 Mar 13. doi: 10.1007/s12149-026-02189.
    >> Share

  59. KITANO Y, Miyake KK, Nobashi TW, Ishimori T, et al
    Correction: Subcutaneous/cutaneous uptake in the cancer-affected breast on (18)F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients.
    Ann Nucl Med. 2026 Mar 13. doi: 10.1007/s12149-026-02188.
    >> Share

  60. SABER TANHA A, Sadeghi R, Ghorbani H, Soltani S, et al
    Lymphatic mapping and sentinel lymph node biopsy in urinary bladder cancer: A SPECT/CT-based experience.
    Ann Nucl Med. 2026 Mar 13. doi: 10.1007/s12149-026-02181.
    >> Share

  61. SHEN TT, Wang QP, Zhang QL, Wu QC, et al
    Application of SPECT/CT muscle imaging in determining the involved muscles in cervical dystonia.
    Ann Nucl Med. 2026 Mar 11. doi: 10.1007/s12149-026-02178.
    >> Share

  62. INABA S, Nawano Y, Ogawa K
    Accurate CT-free correction of attenuation, scatter, and aperture effects using deep learning in dedicated cardiac pinhole SPECT.
    Ann Nucl Med. 2026 Mar 9. doi: 10.1007/s12149-026-02187.
    >> Share

  63. KITANO Y, Miyake KK, Nobashi TW, Ishimori T, et al
    Response to the comment on "Subcutaneous/cutaneous uptake in the cancer-affected breast on (18)F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients".
    Ann Nucl Med. 2026 Mar 6. doi: 10.1007/s12149-026-02186.
    >> Share

  64. CHEN L, Huang Z
    Comment on "Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer".
    Ann Nucl Med. 2026 Mar 3. doi: 10.1007/s12149-026-02185.
    >> Share

  65. DENIZMEN ZORBA D, Has Simsek D, Arslan DF, Isik EG, et al
    Diagnostic value of (6)(8)Ga-DOTATATE PET/CT volumetric parameters in differentiating adrenal lesions.
    Ann Nucl Med. 2026 Mar 3. doi: 10.1007/s12149-026-02175.
    >> Share

  66. CIFTCI E, Akovali B, Gumusgoz HS, Erkek BK, et al
    Predictive value of the (68)Ga-PSMA-11 PET/CT PRIMARY score for pathological upgrading in patients with ISUP Grade 1 prostate cancer and PSA < 20 ng/mL undergoing radical prostatectomy.
    Ann Nucl Med. 2026 Mar 3. doi: 10.1007/s12149-026-02179.
    >> Share

  67. WACHI K, Yamao T, Miwa K, Miyaji N, et al
    Semi-quantitative tau PET approaches for Braak staging: concordance of CenTauRz and STOC with visual assessment.
    Ann Nucl Med. 2026 Mar 2. doi: 10.1007/s12149-026-02184.
    >> Share

  68. MURAO A, Hara K, Oyama S, Ogura A, et al
    Examination of simple artificial intelligence-based analysis of dopamine transporter scintigraphy for supporting a diagnosis of Parkinson's disease.
    Ann Nucl Med. 2026;40:327-335.
    >> Share

  69. TANTIWETCHAYANON K, Matsubara K, Nuntue C, Shibutani T, et al
    Clinical implementation of voxel-based dosimetry using image-based RT-PHITS Monte Carlo simulations for (177)Lu-DOTATATE radionuclide therapy.
    Ann Nucl Med. 2026;40:286-297.
    >> Share

    February 2026
  70. ALTUNDAG K
    Points for clear interpretation of AI-assisted 18 F-FDG PET/CT in breast cancer.
    Ann Nucl Med. 2026 Feb 26. doi: 10.1007/s12149-026-02182.
    >> Share

  71. OZKAN E, Demir B, Seval GC, Araz M, et al
    [(11)C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma.
    Ann Nucl Med. 2026 Feb 25. doi: 10.1007/s12149-026-02180.
    >> Share

  72. WANG R, Dong W, Wang H, Wang J, et al
    The prognostic value of multiparameters derived from D-SPECT in patients with ANOCA.
    Ann Nucl Med. 2026 Feb 19. doi: 10.1007/s12149-026-02173.
    >> Share

  73. AESCHBACHER ND, Maurer A, Beintner-Skawran S, Messerli M, et al
    Doughnut-shaped bone lesions on (18)F-FDG-PET/CT may indicate pseudoprogression under immuno(radio)therapy.
    Ann Nucl Med. 2026 Feb 12. doi: 10.1007/s12149-026-02168.
    >> Share

  74. DEMIR B, Atalay M, Yurtcu HK, Ertek F, et al
    Denoising of PET with SwinUNETR neural networks: impact of tumor oriented loss function, denoising module for 3D slicer.
    Ann Nucl Med. 2026 Feb 8. doi: 10.1007/s12149-026-02166.
    >> Share

  75. SATOH Y, Aoyama S, Itagaki K, Naoi Y, et al
    Comparison of image quality of breast-specific positron emission tomography between opposite-type and ring-shaped systems: insights from Phantom and clinical studies in a Japanese multicenter trial.
    Ann Nucl Med. 2026 Feb 7. doi: 10.1007/s12149-026-02165.
    >> Share

  76. OKUYAMA C, Oishi N, Ishizu K, Hasegawa H, et al
    A new amyloid PET evaluation method using separated gray-matter histogram based on three-component model.
    Ann Nucl Med. 2026 Feb 7. doi: 10.1007/s12149-026-02157.
    >> Share

  77. HOSOKAWA T, Uchiyama M, Namba S, Tanami Y, et al
    Detection rate of lymphoscintigraphy with technetium-99 m for pediatric chylopericardium.
    Ann Nucl Med. 2026 Feb 5. doi: 10.1007/s12149-026-02164.
    >> Share

  78. IWAO Y, Akamatsu G, Sakata M, Wagatsuma K, et al
    Registration accuracy of amyloid/tau-PET to brain MRI using modified SPM method.
    Ann Nucl Med. 2026 Feb 4. doi: 10.1007/s12149-026-02159.
    >> Share

  79. AKSU A, Us A, Guc ZG, Kucuker KA, et al
    Pseudotime-Based derivation of a PET-Based metabolic progression index for prognostic stratification in Extensive-Stage SCLC.
    Ann Nucl Med. 2026 Feb 4. doi: 10.1007/s12149-026-02162.
    >> Share

  80. VIJAYASIMHA M, Srikanth M
    Perfusion-only SPECT/CT for pulmonary thromboembolism: from promising criteria to globally reproducible practice.
    Ann Nucl Med. 2026 Feb 4. doi: 10.1007/s12149-026-02160.
    >> Share

  81. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
    Off-target binding of (18)F-MK-6240 tau PET imaging demonstrated by high spatial resolution dedicated brain PET scanner.
    Ann Nucl Med. 2026 Feb 2. doi: 10.1007/s12149-026-02161.
    >> Share

  82. KESSLER L, Settelmeier S, Pabst KM, Telli T, et al
    Quantitative evaluation of (123)I-MIBG imaging in patients with myocarditis: impairment of cardiac neuronal function revisited.
    Ann Nucl Med. 2026;40:202-208.
    >> Share

  83. LANFRANCHI F, Belgioia L, Vita D, Passoni J, et al
    Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysis.
    Ann Nucl Med. 2026;40:178-187.
    >> Share

  84. BOOIJ J, Chahid Y, Reits EA, Gether U, et al
    The radiotracer [(123)I]I-FP-CIT binds preferentially to the dopamine transporter expressed at the plasma membrane of nigrostriatal dopaminergic neurons: a new concept.
    Ann Nucl Med. 2026;40:101-107.
    >> Share

    January 2026
  85. SHAN HM, Chen T, Fan W
    Predictive value of metabolic parameters from PET/CT in adult multifocal Langerhans cell histiocytosis.
    Ann Nucl Med. 2026 Jan 31. doi: 10.1007/s12149-026-02154.
    >> Share

  86. ITO H, Yamakuni R, Takano H, Abe M, et al
    Regional distribution of an amyloid radiotracer in healthy aged human brain measured by PET with [(18)F]flutemetamol: a relation with myelin distribution.
    Ann Nucl Med. 2026 Jan 23. doi: 10.1007/s12149-026-02158.
    >> Share

  87. MESFIN B, Ishioka Y, Ichinose Y, Inamura A, et al
    Whole-body biodistribution of [(18)F]SMBT-1: a novel PET tracer for monoamine oxidase B imaging in healthy humans.
    Ann Nucl Med. 2026 Jan 7. doi: 10.1007/s12149-025-02144.
    >> Share

  88. MANSOURI Z, Salimi Y, Wolf NB, Hajianfar G, et al
    Deep learning-guided attenuation and scatter correction of (99m)Tc-MAA SPECT images: towards quantitative analysis in (90)Y-SIRT.
    Ann Nucl Med. 2026 Jan 5. doi: 10.1007/s12149-025-02152.
    >> Share

  89. AGHAZADA F, Uslu-Besli L, Kibar A, Sahin OE, et al
    Effect of previous (177)Lu-DOTATATE treatment on (90)Y-microsphere treatment response in neuroendocrine tumor patients with liver metastasis.
    Ann Nucl Med. 2026;40:41-49.
    >> Share

    December 2025
  90. MOCHIZUKI N, Hara T, Masubuchi M, Furuya K, et al
    Software-based de-filtering restores quantitative accuracy in Clarity2D-enhanced whole-body bone scintigraphy.
    Ann Nucl Med. 2025 Dec 29. doi: 10.1007/s12149-025-02145.
    >> Share

  91. SALIMI M, Vadipour P, Khosravi A, Salimi B, et al
    Diagnostic accuracy of (1)(8)F-FDG PET/CT radiomics for non-invasive prediction of PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
    Ann Nucl Med. 2025 Dec 29. doi: 10.1007/s12149-025-02148.
    >> Share

  92. JEONG J, Park BW, Kim YK, Lim CH, et al
    Diagnostic performance of lung perfusion SPECT/CT using perfusion defect and decrease criteria: a comparative study with CTPA in pulmonary thromboembolism.
    Ann Nucl Med. 2025 Dec 24. doi: 10.1007/s12149-025-02147.
    >> Share

  93. BADARCHIN M, Otomi Y, Shinya T, Otsuka H, et al
    Comparative evaluation of CortexID and VIZCalc software in brain amyloid PET: a retrospective study of 116 cases.
    Ann Nucl Med. 2025 Dec 20. doi: 10.1007/s12149-025-02146.
    >> Share

  94. MA H, Xia L, Liu D, Wang S, et al
    (18)F-FDG PET/CT manifestations of extra-adrenal retroperitoneal ganglioneuroma: a retrospective study of 21 cases.
    Ann Nucl Med. 2025 Dec 20. doi: 10.1007/s12149-025-02149.
    >> Share

  95. GU S, Yao L, Duan J, Wang Q, et al
    Clinical utility and future directions of FDG-PET in rectal cancer management.
    Ann Nucl Med. 2025 Dec 19. doi: 10.1007/s12149-025-02143.
    >> Share

  96. LEE N, Kwon SJ, Sung YE, Ahn JH, et al
    Prognostic value of integrated FDG PET/CT avidity and CT morphologic subtypes in invasive mucinous adenocarcinoma of the lung.
    Ann Nucl Med. 2025 Dec 16. doi: 10.1007/s12149-025-02142.
    >> Share

  97. HUO YR, Gupta S, Rutherford N, Saul M, et al
    Utility of serum blood ketone levels and other risk factors for inadequate myocardial glucose suppression ketogenic FDG-PET/CT: a prospective and retrospective cohort study.
    Ann Nucl Med. 2025 Dec 15. doi: 10.1007/s12149-025-02141.
    >> Share

  98. KIND F, Nemer U, Bruggemann K, Jilg CA, et al
    Prognostic value of whole-body tumor SUV dispersion on baseline PSMA PET prior to PSMA radioligand therapy.
    Ann Nucl Med. 2025 Dec 5. doi: 10.1007/s12149-025-02139.
    >> Share

  99. ISHII S, Watanabe H, Saito K, Hara J, et al
    Preoperative diagnostic accuracy of thyroid follicular carcinoma using fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography and blood data.
    Ann Nucl Med. 2025 Dec 4. doi: 10.1007/s12149-025-02135.
    >> Share

  100. YAMADA H, Yokoyama K, Oyama J, Tsuchiya J, et al
    Comparison of MRI-, CT- and PET-based anatomical standardization for Centiloid scale calculation in [(18)F]florbetapir positron emission tomography.
    Ann Nucl Med. 2025 Dec 4. doi: 10.1007/s12149-025-02134.
    >> Share

  101. XIE C, Zhang H, Feng B, Wang Q, et al
    Diagnostic accuracy of artificial intelligence-assisted 18f-fdg pet/ct for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2025 Dec 4. doi: 10.1007/s12149-025-02136.
    >> Share

    November 2025
  102. SUKPRAKUN C, Tepmongkol S
    Diagnostic accuracy of brain perfusion SPECT parameters for seizure onset zone localization in drug-resistant epilepsy.
    Ann Nucl Med. 2025 Nov 25. doi: 10.1007/s12149-025-02128.
    >> Share

  103. LAI R, Jiang Z, Sheng D, Geng Y, et al
    Prognostic value of a combined model integrating clinical and PET radiomics parameters in metastatic melanoma: A dual-center retrospective study.
    Ann Nucl Med. 2025 Nov 22. doi: 10.1007/s12149-025-02133.
    >> Share

  104. KUDOMI N, Mitamura K, Maeda Y, Murao M, et al
    Resolution and quality enhancement of SPECT cerebral blood flow images using Pix2pix deep learning.
    Ann Nucl Med. 2025 Nov 13. doi: 10.1007/s12149-025-02129.
    >> Share

  105. KITANO Y, Miyake KK, Nobashi TW, Ishimori T, et al
    Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and (1)(8)F-FDG PET/CT.
    Ann Nucl Med. 2025 Nov 12. doi: 10.1007/s12149-025-02124.
    >> Share

  106. ALTUNDAG K
    Limitations of an (18)F-FDG PET/CT radiomic nomogram for predicting axillary response in breast cancer.
    Ann Nucl Med. 2025 Nov 10. doi: 10.1007/s12149-025-02125.
    >> Share

  107. ZEB MJ, Choudhry A, Ayub A, Mushtaq S, et al
    Comments on Association between technetium-99 m albumin scintigraphy-based severity of protein-losing enteropathy and patient characteristics and laboratory data.
    Ann Nucl Med. 2025 Nov 10. doi: 10.1007/s12149-025-02130.
    >> Share

  108. KANG J, Kim Y, Jeong Y, Lee HS, et al
    Development and validation of a LASSO-Based FDG PET/CT model for predicting colorectal adenoma in asymptomatic individuals undergoing colonoscopy.
    Ann Nucl Med. 2025 Nov 10. doi: 10.1007/s12149-025-02122.
    >> Share

  109. SOYDAS-TURAN B, Volkan-Salanci B, Aydin B, Ozgen Kiratli P, et al
    Prognostic value of 18F-FDG PET/CT derived metabolic parameters in pediatric osteosarcoma.
    Ann Nucl Med. 2025 Nov 10. doi: 10.1007/s12149-025-02123.
    >> Share

  110. KOKUBUN H, Kijima T, Tokura Y, Uematsu T, et al
    DeltaBSIJ: a quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents.
    Ann Nucl Med. 2025;39:1192-1200.
    >> Share

  111. LIN CY, Tang LH, Chou YH, Ko CL, et al
    Prognostic significance of non-perfusion parameters of cadmium-zinc-telluride single-photon emission computed tomography myocardial perfusion imaging for individuals with normal myocardial perfusion: a large-scale single-center retrospective cohort st
    Ann Nucl Med. 2025;39:1181-1191.
    >> Share

    October 2025
  112. CHOUCHEN M, Badie C, Barki C, Aghaee A, et al
    AI screening of nuclear medicine safety breaches: patterns, causes, and opportunities for improved protocols: a systematic review.
    Ann Nucl Med. 2025 Oct 30. doi: 10.1007/s12149-025-02107.
    >> Share

  113. MENESES-NAVAS MK, Granados-Alcobendas MDM, Amo-Salas M, Garcia-Zoghby L, et al
    Measuring the immeasurable: an approach of nuclear medicine activity using relative value units.
    Ann Nucl Med. 2025 Oct 17. doi: 10.1007/s12149-025-02116.
    >> Share

  114. WANG J, Wu S, Shi A, Zhang H, et al
    Predictive value of (18)F-FDG PET/CT-based radiomics model for lymph node metastasis in esophageal squamous cell carcinoma.
    Ann Nucl Med. 2025 Oct 15. doi: 10.1007/s12149-025-02121.
    >> Share

  115. INUKAI JI, Sah BR, Beintner-Skawran S, Maurer A, et al
    Use of the tracheal bisecting line to differentiate upper pole from lower pole parathyroid adenomas: a PET/MR study using [(18)F]Fluorocholine.
    Ann Nucl Med. 2025 Oct 9. doi: 10.1007/s12149-025-02105.
    >> Share

  116. HUSMANN L, Sah BR, Kotasidis F, Maurer A, et al
    Whole-body dynamic FDG-PET/CT parametric imaging in alveolar echinococcosis.
    Ann Nucl Med. 2025 Oct 6. doi: 10.1007/s12149-025-02113.
    >> Share

  117. KITANO Y, Miyake KK, Nobashi TW, Ishimori T, et al
    Subcutaneous/cutaneous uptake in the cancer-affected breast on (18)F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients.
    Ann Nucl Med. 2025 Oct 5. doi: 10.1007/s12149-025-02106.
    >> Share

  118. JIAMING S, Jiani Y
    Comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer.
    Ann Nucl Med. 2025 Oct 3. doi: 10.1007/s12149-025-02111.
    >> Share

  119. SEBAN RD, Champion L, Buvat I
    Response to "Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer".
    Ann Nucl Med. 2025 Oct 2. doi: 10.1007/s12149-025-02115.
    >> Share

  120. RUZZEH S, Abdlkadir AS, Al-Alawi H, Lopci E, et al
    Evaluating the diagnostic utility of [(6)(8)Ga]Ga-Pentixafor in solid tumors: a systematic review.
    Ann Nucl Med. 2025;39:1053-1073.
    >> Share

  121. WU D, Jiang Q, Shen G, Gao X, et al
    Quantitative analysis of striatal subregional asymmetry on (99m)Tc-TRODAT-1 SPECT and clinical correlations with UPDRS subscales in Parkinson's disease.
    Ann Nucl Med. 2025 Oct 1. doi: 10.1007/s12149-025-02112.
    >> Share

    September 2025
  122. ALTUNDAG K
    Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer.
    Ann Nucl Med. 2025 Sep 30. doi: 10.1007/s12149-025-02114.
    >> Share

  123. LIU C, Song S
    Response to the comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer.
    Ann Nucl Med. 2025 Sep 23. doi: 10.1007/s12149-025-02110.
    >> Share

  124. LUE KH, Wang YH, Chen YH, Chu SC, et al
    The prognostic value of (18)F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy.
    Ann Nucl Med. 2025 Sep 22. doi: 10.1007/s12149-025-02108.
    >> Share

  125. HOSOKAWA T, Uchiyama M, Namba S, Tanami Y, et al
    Association between technetium-99 m albumin scintigraphy-based severity of protein-losing enteropathy and patient characteristics and laboratory data.
    Ann Nucl Med. 2025 Sep 22. doi: 10.1007/s12149-025-02109.
    >> Share

  126. IMAI M, Ochiai Y, Kosaka Y, Mori K, et al
    Impact of body weight on arterial partition coefficient estimation in (123)I-IMP SPECT: a comparison between ARG and no-arterial sampling methods.
    Ann Nucl Med. 2025 Sep 19. doi: 10.1007/s12149-025-02104.
    >> Share

  127. NIFTALIYEVA K, Kesim S, Filizoglu N, Balaban Genc ZC, et al
    Interobserver and intraobserver agreement for equivocal lesions in Ga-68 PSMA PET/CT according to PSMA-RADS 2.0 criteria.
    Ann Nucl Med. 2025 Sep 10. doi: 10.1007/s12149-025-02103.
    >> Share

  128. ABE K, Baba S, Etani R, Fujimto T, et al
    Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan.
    Ann Nucl Med. 2025 Sep 3. doi: 10.1007/s12149-025-02102.
    >> Share

  129. CHEN Z, Wakabayashi H, Mori H, Hiromasa T, et al
    Dynamic expression of the myocardial sigma-1 receptor after doxorubicin cardiomyopathy using radioiodine-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5 V) imaging.
    Ann Nucl Med. 2025;39:973-981.
    >> Share

    August 2025
  130. TANIMOTO K, Kawamura Y, Kimura S, Hasuike Y, et al
    SPECT reconstruction using preprocessing masking for extra-cardiac uptake versus standard processing in (99m)Tc-sestamibi myocardial perfusion imaging.
    Ann Nucl Med. 2025 Aug 26. doi: 10.1007/s12149-025-02085.
    >> Share

  131. LI Y, Chen K, Jin L, Huang H, et al
    Development and validation of an (18)F-FDG PET/CT radiomic nomogram for predicting axillary lymph-node status after neoadjuvant chemotherapy for breast cancer: a multicenter study.
    Ann Nucl Med. 2025 Aug 17. doi: 10.1007/s12149-025-02099.
    >> Share

  132. MA H, Li C, Zhang Q, Liu J, et al
    Diagnostic value of (18)F-FDG PET/CT in the follow-up of conjunctival melanoma.
    Ann Nucl Med. 2025 Aug 15. doi: 10.1007/s12149-025-02097.
    >> Share

  133. SEBAN RD, Rebaud L, Djerroudi L, Vincent-Salomon A, et al
    Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?
    Ann Nucl Med. 2025 Aug 12. doi: 10.1007/s12149-025-02098.
    >> Share

  134. YAMAZAKI K, Higashi T, Nishii R, Terada T, et al
    Validation study on accuracy of our newly proposed methods for post-therapeutic liver reserve capacity estimation utilizing (99 m)Tc-GSA scintigraphy prior to carbon-ion radiotherapy.
    Ann Nucl Med. 2025;39:781-791.
    >> Share

  135. SOYDAS-TURAN B, Yalcin-Cakmakli G, Lay Ergun E, Dasgin H, et al
    Multimodal imaging analysis of autosomal recessive Parkinson's disease.
    Ann Nucl Med. 2025;39:813-822.
    >> Share

  136. KOCAMAN G, Ibrahimov F, Kahya Y, Araz M, et al
    Suvmax of the lesion should be considered in the treatment plan for stage I non-small cell lung cancer.
    Ann Nucl Med. 2025;39:792-798.
    >> Share

    July 2025
  137. CHEN J, Wang Q, Li Y, Song J, et al
    Diagnostic value of FDG PET/CT in determining the etiology of pericardial effusion.
    Ann Nucl Med. 2025 Jul 28. doi: 10.1007/s12149-025-02091.
    >> Share

  138. WATABE T, Hirata K, Iima M, Yanagawa M, et al
    Recent advances in theranostics and oncology PET: emerging radionuclides and targets.
    Ann Nucl Med. 2025 Jul 27. doi: 10.1007/s12149-025-02090.
    >> Share

  139. HINO A, Mizoguchi N, Koge H, Yaguchi R, et al
    Prognostic value of FDG-PET/CT findings in mucosal melanoma of the head and neck treated with carbon ion radiotherapy.
    Ann Nucl Med. 2025 Jul 25. doi: 10.1007/s12149-025-02069.
    >> Share

  140. ITO K, Jinnouchi S, Kikukawa K, Okuyama C, et al
    Clinical Practice Guidelines for (18)F-Fluciclovine 2024 in the Japanese Society of Nuclear Medicine.
    Ann Nucl Med. 2025 Jul 25. doi: 10.1007/s12149-025-02089.
    >> Share

  141. TOYAMA Y, Kotani T, Tamaki N, Yamada S, et al
    Distribution patterns of brown adipose tissue on FDG-PET/CT has age characteristics.
    Ann Nucl Med. 2025 Jul 24. doi: 10.1007/s12149-025-02087.
    >> Share

  142. MIWA K, Yamao T, Hashimoto F, Miyaji N, et al
    Innovations in clinical PET image reconstruction: advances in Bayesian penalized likelihood algorithm and deep learning.
    Ann Nucl Med. 2025 Jul 18. doi: 10.1007/s12149-025-02088.
    >> Share

  143. ENEI Y, Yanagisawa T, Okada A, Kuruma H, et al
    Comparison of diagnostic performance between manual diagnosis following PROMISE V2 and aPROMISE utilizing Ga/F-PSMA PET/CT.
    Ann Nucl Med. 2025 Jul 15. doi: 10.1007/s12149-025-02086.
    >> Share

  144. HIRAOKA K, Mesfin B, Wu Y, Shimizu Y, et al
    Kinetic and quantitative analysis of [(18)F]SMBT-1 PET imaging for monoamine oxidase B.
    Ann Nucl Med. 2025 Jul 15. doi: 10.1007/s12149-025-02083.
    >> Share

  145. ITO R, Kato K, Higashi M, Abe Y, et al
    Vision-language model performance on the Japanese Nuclear Medicine Board Examination: high accuracy in text but challenges with image interpretation.
    Ann Nucl Med. 2025 Jul 15. doi: 10.1007/s12149-025-02084.
    >> Share

  146. WU S, Li C, Lu J, Ge J, et al
    PETFormer-SCL: a supervised contrastive learning-guided CNN-transformer hybrid network for Parkinsonism classification from FDG-PET.
    Ann Nucl Med. 2025 Jul 14. doi: 10.1007/s12149-025-02081.
    >> Share

  147. KHAN D, Jaleel J, Phulia A, Sagar S, et al
    Diagnostic accuracy of 18F-FDG and 68 Ga-FAPi PET/CT for patients with gastric carcinoma: a systematic review and meta-analysis.
    Ann Nucl Med. 2025 Jul 11. doi: 10.1007/s12149-025-02082.
    >> Share

  148. LI H, Li C, Tian Y, Xiao Z, et al
    Same-day dual-tracer PET/CT imaging with [(68) Ga]Ga-FAPI-04 following [(18)F]FDG finds answers in patients presenting with negative or equivocal [(18)F]FDG.
    Ann Nucl Med. 2025 Jul 4. doi: 10.1007/s12149-025-02080.
    >> Share

  149. WAKABAYASHI N, Watanabe S, Takeuchi S, Tsuchikawa T, et al
    Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors.
    Ann Nucl Med. 2025;39:696-706.
    >> Share

  150. FILIZOGLU N, Ozguven S, Kesim S, Oksuzoglu K, et al
    Physiological bio-distribution of (68)Ga-DOTA-TATE in pediatric patients.
    Ann Nucl Med. 2025;39:650-662.
    >> Share

    June 2025
  151. TAMURA K, Nishii R, Tsuji AB, Tsukada J, et al
    Prognostic value of pre-treatment metabolic tumor volume on [S?methyl?(11)C]?L?methionine PET/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy.
    Ann Nucl Med. 2025 Jun 30. doi: 10.1007/s12149-025-02067.
    >> Share

  152. LEE SW, Jeong SY, Kim SJ
    Diagnostic performance of FDG PET/CT radiomics in predicting microvascular invasion in hepatocellular carcinoma compared to conventional metabolic parameters: a systematic review and meta-analysis.
    Ann Nucl Med. 2025 Jun 28. doi: 10.1007/s12149-025-02075.
    >> Share

  153. ZAMBRANO-INFANTINO RDC, Pinerua-Gonsalvez JF, Sebastian-Palacid F, Alvarez-Mena N, et al
    From image to index: diagnostic accuracy of a novel semi-quantitative approach for assessing suspected periprosthetic joint infection with triple-phase bone scintigraphy.
    Ann Nucl Med. 2025 Jun 26. doi: 10.1007/s12149-025-02076.
    >> Share

  154. LIU C, Pan D, Sun Y, Xu X, et al
    The role of dual-tracer PET imaging with ER and HER2 in patients with metastatic breast cancer: a pilot study.
    Ann Nucl Med. 2025 Jun 26. doi: 10.1007/s12149-025-02071.
    >> Share

  155. OMASA W, Matsumoto K, Shimizu K, Ohara N, et al
    Measurement accuracy and practicality of (15)O-gas PET using a high-sensitivity whole-body PET/CT scanner.
    Ann Nucl Med. 2025 Jun 25. doi: 10.1007/s12149-025-02073.
    >> Share

  156. TAN X, Zhou Y, Zhang Q, Yuan H, et al
    Assessment of reduced (18)F-FDG dosage in pediatric PET/MR imaging through randomized down-sampling.
    Ann Nucl Med. 2025 Jun 17. doi: 10.1007/s12149-025-02066.
    >> Share

  157. HE X, Li J, Wang L, Xie Y, et al
    A comparative study of dual-layer spectral CT and 18F-FDG-PET/CT multi-quantitative parameters in the diagnosis of sentinel lymph nodes in breast cancer.
    Ann Nucl Med. 2025 Jun 17. doi: 10.1007/s12149-025-02074.
    >> Share

  158. FUKUI Y, Baba S, Ohashi K, Nagatani Y, et al
    Evaluation of the feasibility of anomaly detection for dose management in PET examinations.
    Ann Nucl Med. 2025 Jun 16. doi: 10.1007/s12149-025-02063.
    >> Share

  159. CHAREST M, Belair MA
    From planar to SPECT-CT brain perfusion study in brain death determination: our experience from 2010 to 2023.
    Ann Nucl Med. 2025 Jun 15. doi: 10.1007/s12149-025-02068.
    >> Share

  160. SHIRAI Y, Nagao M, Inoue A, Yamamoto A, et al
    Diagnosis of cardiac sarcoidosis using glucose metabolic rate from four-dimensional (18)F-FDG PET/CT.
    Ann Nucl Med. 2025 Jun 14. doi: 10.1007/s12149-025-02070.
    >> Share

  161. ZHANG X, Nakajima K, Acampa W, Assante R, et al
    Establishment of a (123)I-meta-iodobenzylguanidine normal database for D-SPECT using Japanese and Italian data.
    Ann Nucl Med. 2025 Jun 2. doi: 10.1007/s12149-025-02061.
    >> Share

  162. LIU YS, Wang L, Song HY, Wang L, et al
    Radiomics of lung ventilation/perfusion tomographic imaging in pulmonary embolism diagnosis.
    Ann Nucl Med. 2025;39:608-617.
    >> Share

    May 2025
  163. SCHAEBEL GH, Johannesen HH, Lofgren J, Gutte H, et al
    The prognostic value of positron emission tomography/magnetic resonance imaging in predicting survival in patients with adenocarcinoma of the esophagogastric junction.
    Ann Nucl Med. 2025 May 17. doi: 10.1007/s12149-025-02058.
    >> Share

  164. TAMURA K, Tsuji AB, Nishii R, Tani K, et al
    A first-in-man PET study of 2-amino-[3-(11)C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers.
    Ann Nucl Med. 2025 May 13. doi: 10.1007/s12149-025-02059.
    >> Share

  165. HUA Q, Wang N, Wang D, Wen J, et al
    Feasibility and mechanism of (68)Ga-FAPI PET/CT in monitoring chemoresistance of non-small cell lung cancer.
    Ann Nucl Med. 2025 May 11. doi: 10.1007/s12149-025-02056.
    >> Share

  166. WANG K, Wang X, Meng X, Zhang G, et al
    Molecular imaging using (18)F-FDG PET/CT and circulating inflammatory and immune indicators to predict pathological response to neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB NSCLC.
    Ann Nucl Med. 2025 May 10. doi: 10.1007/s12149-025-02057.
    >> Share

  167. ROSHANRAVAN V, Ghorbani H, Soltani S, Shabani E, et al
    The diagnostic value of whole-body HYNIC-PSMA 11 -Tc [(99 m)Tc] SPECT/CT scan in early staging of patients with moderate- and high-risk prostate cancer.
    Ann Nucl Med. 2025 May 10. doi: 10.1007/s12149-025-02055.
    >> Share

  168. LU J, Chen K, Lin H, Ju Z, et al
    Phenotype-specific metabolic patterns in Posterior cortical atrophy and early-onset typical Alzheimer's disease.
    Ann Nucl Med. 2025;39:506-517.
    >> Share

  169. AKGUN E, Erdim C, Ibicioglu B, Guzelbey T, et al
    Is there any effect of hcc location on selective internal radiation therapy with (90)yttrium response?
    Ann Nucl Med. 2025;39:527-534.
    >> Share

  170. OYA A, Nakayama M, Uno T, Ueda H, et al
    Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras.
    Ann Nucl Med. 2025;39:466-475.
    >> Share

    April 2025
  171. KOBATA T, Norikane T, Murao M, Manabe Y, et al
    Test for shortening the computation time for imaging of appearance time for cerebral blood using H(2)(15)O and positron emission tomography.
    Ann Nucl Med. 2025 Apr 29. doi: 10.1007/s12149-025-02054.
    >> Share

  172. YAMAKUNI R, Abe M, Ukon N, Matsuda H, et al
    Comparison and cutoff values of two amyloid PET scaling methods: centiloid scale and amyloid-beta load.
    Ann Nucl Med. 2025 Apr 26. doi: 10.1007/s12149-025-02051.
    >> Share

  173. DEMIR B, Kucuk NO, Soydal C, Celebioglu EC, et al
    Comparative voxel-based dosimetry with pre-treatment Tc-99m SPECT/CT and post-treatment Y-90 PET/MRI for radioembolization with Y-90 microspheres.
    Ann Nucl Med. 2025 Apr 23. doi: 10.1007/s12149-025-02052.
    >> Share

  174. TAKEMOTO S, Onuki K, Tanimoto K, Taniguchi M, et al
    Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using (18)F-flutemetamol.
    Ann Nucl Med. 2025 Apr 19. doi: 10.1007/s12149-025-02046.
    >> Share

  175. MATSUTOMO N, Fukami M, Yamamoto T
    Can interactive artificial intelligence be used for patient explanations of nuclear medicine examinations in Japanese?
    Ann Nucl Med. 2025 Apr 16. doi: 10.1007/s12149-025-02047.
    >> Share

  176. HOTTA M, Horikawa D, Kurihara K, Ohashi S, et al
    Pre-treatment (111)In-pentetreotide SPECT/CT vs. baseline (177)Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?
    Ann Nucl Med. 2025 Apr 14. doi: 10.1007/s12149-025-02050.
    >> Share

  177. PEI Y, Tong Y, Wang Z, Qiao X, et al
    Analysis of the best time-point for 18F-FDG PET/CT delayed imaging in patients of small colorectal cancer liver metastasis with hypothyroidism based on diagnostic efficacy and image standardized uptake values.
    Ann Nucl Med. 2025 Apr 2. doi: 10.1007/s12149-025-02045.
    >> Share

  178. ZHANG Z, Ma Z, Wang X, Zhou Y, et al
    Specific molecular imaging of BALB/c model mice with Graves' ophthalmopathy based on high expression of insulin-like growth factor 1 receptor.
    Ann Nucl Med. 2025;39:388-397.
    >> Share

  179. LIU Y, Wang F, Song Y, Zhou X, et al
    First study on the efficiency of (99m)Tc-rituximab for sentinel lymph node mapping and biopsy in oral squamous cell carcinoma.
    Ann Nucl Med. 2025;39:380-387.
    >> Share

  180. LIM CH, Lee JH, Lee J, Park SB, et al
    Predictive value of (18)F-fluorodeoxyglucose uptake for axillary lymph node metastasis in operable breast cancer: impact of molecular subtypes.
    Ann Nucl Med. 2025;39:315-322.
    >> Share

    March 2025
  181. LU D, Zhu X, Mu X, Huang X, et al
    Development and validation of a nomogram for predicting bone marrow involvement in lymphoma patients based on (18)F-FDG PET radiomics and clinical factors.
    Ann Nucl Med. 2025 Mar 29. doi: 10.1007/s12149-025-02041.
    >> Share

  182. BUDDENKOTTE T, Lange C, Klutmann S, Apostolova I, et al
    Fully automatic categorical analysis of striatal subregions in dopamine transporter SPECT using a convolutional neural network.
    Ann Nucl Med. 2025 Mar 16. doi: 10.1007/s12149-025-02038.
    >> Share

  183. HUANG S, Zhang Y, Zhang W, Tian T, et al
    Metabolic tumor parameters on (18)F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.
    Ann Nucl Med. 2025 Mar 15. doi: 10.1007/s12149-025-02039.
    >> Share

  184. RAINIO O, Karpijoki H, Knuuti J, Klen R, et al
    Pulmonary blood flow quantification in humans from 15O-water PET.
    Ann Nucl Med. 2025 Mar 14. doi: 10.1007/s12149-025-02035.
    >> Share

  185. ZHANG MX, Liu PF, Zhang MD, Su PG, et al
    Deep learning in nuclear medicine: from imaging to therapy.
    Ann Nucl Med. 2025 Mar 13. doi: 10.1007/s12149-025-02031.
    >> Share

  186. GARCIA MEGIAS I, Almeida LS, Calapaqui Teran AK, Pabst KM, et al
    FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?
    Ann Nucl Med. 2025 Mar 11. doi: 10.1007/s12149-025-02022.
    >> Share

  187. WANG M, Quan Z, Xin K, Li G, et al
    Superiority of (68)Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting.
    Ann Nucl Med. 2025 Mar 11. doi: 10.1007/s12149-025-02033.
    >> Share

  188. GAUTHAMAN DK, Muthukrishnan I, Acharya KA, Simon S, et al
    Ga-68 Pentixafor PET/CT in multiple myeloma and its correlation with clinical parameters: institutional pilot study.
    Ann Nucl Med. 2025 Mar 7. doi: 10.1007/s12149-025-02036.
    >> Share

  189. MU X, Zhu Z, Wang Z, Li X, et al
    Insights into lung cancer diagnosis and clinical management using [(18)F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT).
    Ann Nucl Med. 2025 Mar 7. doi: 10.1007/s12149-025-02032.
    >> Share

  190. MORI Y, Tamburini K, Novruzov E, Schmitt D, et al
    Efficacy of [(68)Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis.
    Ann Nucl Med. 2025 Mar 6. doi: 10.1007/s12149-025-02027.
    >> Share

  191. LIU H, Meng X, Wang G, Yao S, et al
    Differentiating second primary lung cancer from pulmonary metastasis in patients of single solitary pulmonary lesion with extrapulmonary tumor using multiparametric analysis of FDG PET/CT.
    Ann Nucl Med. 2025 Mar 5. doi: 10.1007/s12149-025-02034.
    >> Share

  192. KATAHIRA M, Fukushima K, Endo K, Kawakubo M, et al
    Feasibility of position emission tomography derived endocardial wall strain: direct comparison with magnetic resonance using hybrid (13)N ammonia PETMR system.
    Ann Nucl Med. 2025;39:285-294.
    >> Share

  193. AGGARWAL P, Gunasekaran V, Gowtham M, Mahajan JK, et al
    Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by (99m)Tc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging.
    Ann Nucl Med. 2025;39:266-272.
    >> Share

    February 2025
  194. WU H, Liu G, Ruan X, Zhang B, et al
    A low-dose protocol in pediatric (18)F-FDG scans using 30-cm axis field of view PET/CT.
    Ann Nucl Med. 2025 Feb 28. doi: 10.1007/s12149-025-02030.
    >> Share

  195. ALBANO D, Temponi A, Bertagna F, Suardi N, et al
    The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer.
    Ann Nucl Med. 2025 Feb 17. doi: 10.1007/s12149-025-02026.
    >> Share

  196. JIMENEZ LONDONO GA, Perez-Beteta J, Amo-Salas M, Honguero-Martinez AF, et al
    Clinicopathologic and metabolic variables from (18)F-FDG PET/CT in the prediction of recurrence pattern in stage I-III non-small cell lung cancer after curative surgery.
    Ann Nucl Med. 2025 Feb 13. doi: 10.1007/s12149-025-02021.
    >> Share

  197. HIRATA K, Matsui Y, Yamada A, Fujioka T, et al
    Correction: Generative AI and large language models in nuclear medicine: current status and future prospects.
    Ann Nucl Med. 2025 Feb 11. doi: 10.1007/s12149-025-02024.
    >> Share

  198. ABD-ELKADER MS, Elmaghraby SM, Abdel-Mohsen MA, Khalil MM, et al
    Correction: Estimation of liver standardized uptake value in F18-FDG PET/CT scanning: impact of different malignancies, blood glucose level, body weight normalization, and imaging systems.
    Ann Nucl Med. 2025 Feb 2. doi: 10.1007/s12149-025-02019.
    >> Share

  199. KINUYA S
    Congratulations on the 60th anniversary of the Japanese Society of Nuclear Medicine.
    Ann Nucl Med. 2025 Feb 1. doi: 10.1007/s12149-024-02008.
    >> Share

  200. HUANG J, Li J, Li Z, Qin J, et al
    Assessing osteoporosis and bone mineral density through (18)F-NaF uptake at lumbar spine.
    Ann Nucl Med. 2025;39:150-157.
    >> Share

    January 2025
  201. MATSUDA H, Hanyu H, Kaneko C, Ogura M, et al
    Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer's disease patients.
    Ann Nucl Med. 2025 Jan 28. doi: 10.1007/s12149-025-02018.
    >> Share

  202. TATSUMI M, Morita N, Kida A, Momoi R, et al
    Effects of data-driven respiratory gating on visualization and quantification of breast and upper abdominal cancers in FDG PET/CT examinations.
    Ann Nucl Med. 2025 Jan 23. doi: 10.1007/s12149-025-02017.
    >> Share

  203. RAINIO O, Klen R
    Compartmental modeling for blood flow quantification from dynamic 15 O-water PET images of humans: a systematic review.
    Ann Nucl Med. 2025 Jan 20. doi: 10.1007/s12149-025-02014.
    >> Share

  204. ZHANG G, Shen J, Hu T, Zheng W, et al
    Utility of (18)F-FDG PET/CT metabolic parameters on post-transplant lymphoproliferative disorder diagnosis.
    Ann Nucl Med. 2025 Jan 18. doi: 10.1007/s12149-025-02016.
    >> Share

  205. GUGLIELMO P, Buffi N, Porreca A, Setti L, et al
    Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.
    Ann Nucl Med. 2025 Jan 15. doi: 10.1007/s12149-025-02015.
    >> Share

  206. ROSHAN A, Pasha T, Kounidas G, Murphy S, et al
    Next day sentinel node biopsy for melanoma after lymphoscintigraphy using (99m)Tc-labelled nanocolloid does not adversely affect long-term outcomes.
    Ann Nucl Med. 2025;39:77-85.
    >> Share

  207. YAMA N, Tatsumi H, Akatsuka M, Hatakenaka M, et al
    Blood-pool SUV analysis of 99mTc-galactosyl human serum albumin (99mTc-GSA) normalized by blood volume for prediction of short-term survival in severe liver failure: preliminary report.
    Ann Nucl Med. 2025;39:58-67.
    >> Share

    December 2024
  208. DE RUITER RD, Zwama J, Raijmakers PGHM, Yaqub M, et al
    Validation of quantitative [(18)F]NaF PET uptake parameters in bone diseases: a systematic review.
    Ann Nucl Med. 2024 Dec 27. doi: 10.1007/s12149-024-01991.
    >> Share

  209. OKUYAMA C, Inuzuka Y, Takeuchi Y, Asagoe K, et al
    Imaging of cardiac amyloidosis using dynamic (18)F-FPYBF-2 positron emission tomography.
    Ann Nucl Med. 2024 Dec 20. doi: 10.1007/s12149-024-02010.
    >> Share

  210. LI S, Sang B, Liu J, Liu Y, et al
    Application of modified Curie and SIOPEN skeleton scoring systems in (18)F-AlF-NOTA-octreotide PET/CT for neuroblastoma.
    Ann Nucl Med. 2024 Dec 15. doi: 10.1007/s12149-024-02006.
    >> Share

  211. ZHOU X, Yan S, Li D, Zhu H, et al
    Radiolabelled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer.
    Ann Nucl Med. 2024 Dec 14. doi: 10.1007/s12149-024-02009.
    >> Share

  212. SAGARA H, Inoue K, Mano C, Kajiwara H, et al
    Usefulness of a new anthropomorphic phantom simulating the chest and abdomen regions in PET tests.
    Ann Nucl Med. 2024 Dec 7. doi: 10.1007/s12149-024-02007.
    >> Share

  213. FUJII H, Toyama H, Kayano D, Ishii K, et al
    The 13th World Federation of Nuclear Medicine and Biology congress (WFNMB 2022): summarize the past half century and discuss the next half century of WFNMB.
    Ann Nucl Med. 2024 Dec 2. doi: 10.1007/s12149-024-01999.
    >> Share

  214. SHIN S, Nam HY, Kim K, Kim J, et al
    Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson's disease: a Bayesian approach.
    Ann Nucl Med. 2024;38:989-998.
    >> Share

    November 2024
  215. CHAN SC, Chiu TL, Ng SH, Kao HW, et al
    (18)F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study.
    Ann Nucl Med. 2024 Nov 26. doi: 10.1007/s12149-024-02005.
    >> Share

  216. USLU H, Sahin D, Ibisoglu E, Tatoglu MT, et al
    PRIMARY scoring in 68Ga-PSMA PET/CT: correlation with prostate cancer risk groups and its potential impact on active surveillance.
    Ann Nucl Med. 2024 Nov 23. doi: 10.1007/s12149-024-02004.
    >> Share

  217. WATANABE T, Baba A, Fukuda T, Watanabe K, et al
    Role of visual information in multimodal large language model performance: an evaluation using the Japanese nuclear medicine board examination.
    Ann Nucl Med. 2024 Nov 13. doi: 10.1007/s12149-024-01992.
    >> Share

  218. AMASHA AAH, Kasalak O, Glaudemans AWJM, Noordzij W, et al
    Increased individual workload for nuclear medicine physicians over the past years: 2008-2023 data from The Netherlands.
    Ann Nucl Med. 2024 Nov 10. doi: 10.1007/s12149-024-01995.
    >> Share

  219. SUN X, Zhang G, Zhang Q, Yuan H, et al
    Comparison of early and standard (18)F-PSMA-11 PET/CT imaging in treatment-naive patients with prostate cancer.
    Ann Nucl Med. 2024 Nov 10. doi: 10.1007/s12149-024-02000.
    >> Share

  220. NAKAMOTO Y, Inui Y, Hotta M, Wakabayashi H, et al
    Recent advancements in new tracers from first-in-human studies.
    Ann Nucl Med. 2024;38:877-883.
    >> Share

  221. TAKAI G, Hanaoka K, Nagano K, Okada T, et al
    Prediction of 1 cm dose-equivalent rate on the day after administration of (177)Lu-DOTATATE from (111)In-somatostatine receptor scintigraphy prior to treatment.
    Ann Nucl Med. 2024;38:927-932.
    >> Share

  222. LING SW, van der Veldt A, Segbers M, Luiting H, et al
    Tubarial salivary glands show a low relative contribution to functional salivary gland tissue mass.
    Ann Nucl Med. 2024;38:913-918.
    >> Share

  223. HANDAYANI W, Chantadisai M, Phromphao B, Noipinit N, et al
    Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment.
    Ann Nucl Med. 2024;38:884-893.
    >> Share

    October 2024
  224. SASAKI Y
    The 1st World Congress of Nuclear Medicine and Biology held in Japan: a historical review with personal reminiscences.
    Ann Nucl Med. 2024 Oct 30. doi: 10.1007/s12149-024-01988.
    >> Share

  225. WATANABE M, Fendler WP, Grafe H, Hirmas N, et al
    Head-to-head comparison of (68) Ga-FAPI-46 PET/CT, (18)F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors.
    Ann Nucl Med. 2024 Oct 23. doi: 10.1007/s12149-024-01993.
    >> Share

  226. ABD-ELKADER MS, Elmaghraby SM, Abdel-Mohsen MA, Khalil MM, et al
    Estimation of liver standardized uptake value in F18-FDG PET/CT scanning: impact of different malignancies, blood glucose level, body weight normalization, and imaging systems.
    Ann Nucl Med. 2024 Oct 16. doi: 10.1007/s12149-024-01985.
    >> Share

  227. SHAGERA QA, Gil T, Barraco E, Boegner P, et al
    Evaluating response to radium-223 using (68)Ga-PSMA PET/CT imaging in patients with metastatic castration-resistant prostate cancer.
    Ann Nucl Med. 2024 Oct 5. doi: 10.1007/s12149-024-01990.
    >> Share

  228. DAUNGSUPAWONG H, Wiwanitkit V
    Impact of recent COVID-19 infection on perfusion and functional parameters derived from gated myocardial perfusion imaging in patients undergoing evaluation for coronary artery disease: correspondence.
    Ann Nucl Med. 2024;38:852.
    >> Share

  229. KAPLAN I, Komek H, Can C, Akdeniz N, et al
    Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?
    Ann Nucl Med. 2024;38:825-834.
    >> Share

  230. ALVANDI M, Shaghaghi Z, Fatehi Z, Naghshtabrizi B, et al
    Exploring the impact of recent COVID-19 infection on perfusion and functional parameters derived from gated myocardial perfusion imaging in patients undergoing evaluation for coronary artery disease.
    Ann Nucl Med. 2024;38:789-794.
    >> Share

    September 2024
  231. YAMADA T, Hanaoka K, Morimoto-Ishikawa D, Yamakawa Y, et al
    Crossover evaluation of time-of-flight-based attenuation correction in brain (18)F-FDG and (18)F-flutemetamol PET.
    Ann Nucl Med. 2024 Sep 30. doi: 10.1007/s12149-024-01986.
    >> Share

  232. BOKTOR RR, Berlangieri SU, Lau E, Lim A, et al
    (18)F-FDG PET/CT biomarkers as predictors of long term outcomes and survival rates in patients with high risk malignant pulmonary masses/nodules treated with stereotactic ablative radiotherapy.
    Ann Nucl Med. 2024 Sep 28. doi: 10.1007/s12149-024-01983.
    >> Share

  233. HIRATA K, Matsui Y, Yamada A, Fujioka T, et al
    Generative AI and large language models in nuclear medicine: current status and future prospects.
    Ann Nucl Med. 2024 Sep 25. doi: 10.1007/s12149-024-01981.
    >> Share

  234. TAKENAKA A, Nihashi T, Sakurai K, Notomi K, et al
    Interrater agreement and variability in visual reading of [18F] flutemetamol PET images.
    Ann Nucl Med. 2024 Sep 24. doi: 10.1007/s12149-024-01977.
    >> Share

  235. BELGE BILGIN G, Bilgin C, Orscelik A, Burkett BJ, et al
    Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2024 Sep 17. doi: 10.1007/s12149-024-01978.
    >> Share

  236. JIA Y, Hu Y, Yang L, Diao X, et al
    Prognostic value of transient ischemic dilatation by (13)N-ammonia PET MPI for short-term outcomes in patients with non-obstructive CAD.
    Ann Nucl Med. 2024 Sep 9. doi: 10.1007/s12149-024-01976.
    >> Share

  237. KANAYA H, Shiraishi S, Ogasawara K, Iwashita K, et al
    Inverse correlation between age of onset and myocardial amyloid deposition quantified by (99m)Tc-PYP scintigraphy in patients with wild-type transthyretin amyloid cardiomyopathy.
    Ann Nucl Med. 2024;38:744-753.
    >> Share

  238. WANG N, Qu S, Kong W, Hua Q, et al
    Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics.
    Ann Nucl Med. 2024;38:734-743.
    >> Share

  239. HOSOKAWA T, Uchiyama M, Tanami Y, Sato Y, et al
    Booster administration of Tc-99m PMT for delayed static imaging in patients with biliary atresia.
    Ann Nucl Med. 2024;38:711-725.
    >> Share

    August 2024
  240. GELBART E, Krakovich A, Sherm Y, Rabin G, et al
    Validation of advanced hybrid SPECT/CT system using dynamic anthropomorphic cardiac phantom.
    Ann Nucl Med. 2024 Aug 30. doi: 10.1007/s12149-024-01966.
    >> Share

  241. KISO K, Nakajima K, Nimura Y, Nishimura T, et al
    A novel algorithm developed using machine learning and a J-ACCESS database can estimate defect scores from myocardial perfusion single-photon emission tomography images.
    Ann Nucl Med. 2024 Aug 29. doi: 10.1007/s12149-024-01971.
    >> Share

  242. TSUZURA K, Wagatsuma K, Kamitaka Y, Miwa K, et al
    Phantom test procedures for a new neuro-oncological amino acid PET tracer: [(18)F]fluciclovine.
    Ann Nucl Med. 2024 Aug 29. doi: 10.1007/s12149-024-01973.
    >> Share

  243. DEMIR B, Soydal C, Kucuk NO, Celebioglu EC, et al
    Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres.
    Ann Nucl Med. 2024 Aug 29. doi: 10.1007/s12149-024-01974.
    >> Share

  244. XIN K, Ma X, Meng X, Zhang X, et al
    Assessment of myocardial injury by SPECT myocardial perfusion imaging in patients with COVID-19 infection in a single center after lifting the restrictions in China.
    Ann Nucl Med. 2024 Aug 26. doi: 10.1007/s12149-024-01970.
    >> Share

  245. SERAPHIM DM, Koga KH, Vacavant A, de Pina DR, et al
    How anatomical impairments found on CT affect perfusion percentage assessed by SPECT/CT scan?
    Ann Nucl Med. 2024 Aug 24. doi: 10.1007/s12149-024-01969.
    >> Share

  246. MIZUMURA S, Tamamura N, Ebina J, Watanabe H, et al
    Quantitative evaluation of striatal uptake ratios using an adaptive template registration method for (123)I-ioflupane dopamine transporter SPECT.
    Ann Nucl Med. 2024 Aug 19. doi: 10.1007/s12149-024-01968.
    >> Share

  247. HOU X, He Y, Liu G, Chen S, et al
    SPECT/CT imaging: quantifying (99m)Tc-MDP concentration in the spine and pelvis.
    Ann Nucl Med. 2024 Aug 18. doi: 10.1007/s12149-024-01967.
    >> Share

  248. YAP WK, Hsu KH, Wang TH, Lin CH, et al
    The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis.
    Ann Nucl Med. 2024;38:607-618.
    >> Share

  249. JELTEMA HR, van Dijken BRJ, Tamasi K, Drost G, et al
    (11)C-Methionine uptake in meningiomas after stereotactic radiotherapy.
    Ann Nucl Med. 2024;38:596-606.
    >> Share

    July 2024
  250. WUMENER X, Zhang Y, Zang Z, Ye X, et al
    The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer.
    Ann Nucl Med. 2024 Jul 29. doi: 10.1007/s12149-024-01964.
    >> Share

  251. MIRBOD M, Ayubcha C, Redden HWK, Teichner E, et al
    FDG-PET in the diagnosis of primary progressive aphasia: a systematic review.
    Ann Nucl Med. 2024 Jul 19. doi: 10.1007/s12149-024-01958.
    >> Share

  252. ARCAY OZTURK A, Erkilic M, Bural GG, Aydin F, et al
    Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution.
    Ann Nucl Med. 2024 Jul 9. doi: 10.1007/s12149-024-01957.
    >> Share

  253. SHIMIZU Y, Ando M, Watanabe H, Ono M, et al
    Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer.
    Ann Nucl Med. 2024 Jul 8. doi: 10.1007/s12149-024-01959.
    >> Share

  254. COSKUN N, Kartal MO, Kartal AS, Cayhan V, et al
    Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres.
    Ann Nucl Med. 2024;38:525-533.
    >> Share

  255. YIN H, Liu G, Mao W, Lv J, et al
    Parametric net influx rate imaging of (68)Ga-DOTATATE in patients with neuroendocrine tumors: assessment of lesion detectability.
    Ann Nucl Med. 2024;38:483-492.
    >> Share

    June 2024
  256. OKUYAMA C, Higashi T, Ishizu K, Oishi N, et al
    New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map.
    Ann Nucl Med. 2024 Jun 22. doi: 10.1007/s12149-024-01956.
    >> Share

  257. YAMAKUNI R, Murakami T, Ukon N, Kakamu T, et al
    Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI.
    Ann Nucl Med. 2024 Jun 20. doi: 10.1007/s12149-024-01955.
    >> Share


  258. Correction to: Annals of Nuclear Medicine.
    Ann Nucl Med. 2024 Jun 19. doi: 10.1007/s12149-024-01953.
    >> Share

  259. LIANG H, Tan W, Wang J, Li M, et al
    Novel prediction model combining PET/CT metabolic parameters, inflammation markers, and TNM stage: prospects for personalizing prognosis in nasopharyngeal carcinoma.
    Ann Nucl Med. 2024 Jun 14. doi: 10.1007/s12149-024-01949.
    >> Share

  260. JAFARITADI M, Teuho J, Lehtonen E, Klen R, et al
    Deep generative denoising networks enhance quality and accuracy of gated cardiac PET data.
    Ann Nucl Med. 2024 Jun 6. doi: 10.1007/s12149-024-01945.
    >> Share

  261. TAKAHASHI K, Manabe O, Shizukuishi K, Shibata H, et al
    Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
    Ann Nucl Med. 2024;38:409-417.
    >> Share

  262. CHIMURA M, Ohtani T, Sera F, Higuchi R, et al
    Novel indices representing heterogeneous distributions of myocardial perfusion imaging.
    Ann Nucl Med. 2024;38:468-474.
    >> Share

  263. LI Y, Yang Z, Yin P, Gao X, et al
    Quantitative analysis of abdominal aortic blood flow by (99m)Tc-DTPA renal scintigraphy in patients with heart failure.
    Ann Nucl Med. 2024;38:418-427.
    >> Share

    May 2024
  264. MIYAJIMA I, Yoshikawa A, Sahashi K, Seki C, et al
    DOCK-PET: database of CNS kinetic parameters in the healthy human brain for existing PET tracers.
    Ann Nucl Med. 2024 May 30. doi: 10.1007/s12149-024-01947.
    >> Share

  265. MOON JW, Song YH, Kim YN, Woo JY, et al
    [(18)F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings-a bicenter retrospective study.
    Ann Nucl Med. 2024 May 25. doi: 10.1007/s12149-024-01944.
    >> Share

  266. BURASOTHIKUL P, Navikhacheevin C, Pasawang P, Sontrapornpol T, et al
    Dual-time-point dynamic (68)Ga-PSMA-11 PET/CT for parametric imaging generation in prostate cancer.
    Ann Nucl Med. 2024 May 18. doi: 10.1007/s12149-024-01939.
    >> Share

  267. NAKAMOTO R, Yakami M, Nobashi TW, Isoda H, et al
    The effect of hormone therapy on physiological uptake of the endometrium on [(18)F]F-FDG PET in postmenopausal women.
    Ann Nucl Med. 2024 May 18. doi: 10.1007/s12149-024-01941.
    >> Share

  268. INAKI A, Mizokami A, Wakabayashi H, Izumi K, et al
    Evaluation of (68)Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer.
    Ann Nucl Med. 2024 May 16. doi: 10.1007/s12149-024-01931.
    >> Share

  269. DATTA D, Selvakumar B, Goel AD, Chhibber S, et al
    Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis.
    Ann Nucl Med. 2024 May 15. doi: 10.1007/s12149-024-01934.
    >> Share

  270. TOMONARI Y, Onishi Y, Hashimoto F, Ote K, et al
    Animal PET scanner with a large field of view is suitable for high-throughput scanning of rodents.
    Ann Nucl Med. 2024 May 8. doi: 10.1007/s12149-024-01937.
    >> Share

  271. LUE KH, Chen YH, Chu SC, Lin CB, et al
    Prognostic value of combining clinical factors, (18)F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation st
    Ann Nucl Med. 2024 May 5. doi: 10.1007/s12149-024-01936.
    >> Share

  272. LIU M, Yao A, Li Z, Zhang J, et al
    Properties of [(18)F]FAPI monitoring of acute radiation pneumonia versus [(18)F]FDG in mouse models.
    Ann Nucl Med. 2024;38:360-368.
    >> Share

  273. JI X, Zhu G, Gou J, Chen S, et al
    A fully automatic deep learning-based method for segmenting regions of interest and predicting renal function in pediatric dynamic renal scintigraphy.
    Ann Nucl Med. 2024;38:382-390.
    >> Share

    April 2024
  274. ARAK H, Elboga U, Cayirli YB, Aytekin A, et al
    Prognostic significance of (68) Ga-FAPI PET/CT in patients with bone metastases in various cancers.
    Ann Nucl Med. 2024 Apr 30. doi: 10.1007/s12149-024-01935.
    >> Share

  275. USMANI S, Ahmed N, Gnanasegaran G, Marafi F, et al
    Assessment of regional and total skeletal metabolism using (18)F-NaF PET/CT in patients with chronic kidney disease.
    Ann Nucl Med. 2024 Apr 27. doi: 10.1007/s12149-024-01929.
    >> Share

  276. SUNG C, Oh JS, Park BS, Kim SS, et al
    Diagnostic performance of a deep-learning model using (18)F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer.
    Ann Nucl Med. 2024 Apr 8. doi: 10.1007/s12149-024-01925.
    >> Share

  277. HOSSEINI SA, Shiri I, Ghaffarian P, Hajianfar G, et al
    The effect of harmonization on the variability of PET radiomic features extracted using various segmentation methods.
    Ann Nucl Med. 2024 Apr 4. doi: 10.1007/s12149-024-01923.
    >> Share

  278. GUO H, Wu S, Xiang X, Wang S, et al
    Performance of (99m)Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis.
    Ann Nucl Med. 2024;38:288-295.
    >> Share

    March 2024
  279. JIN L, Zhang L, Fu L, Song F, et al
    18F-FDG PET/CT metabolism multi-parameter prediction of chemotherapy efficacy in locally progressive gastric cancer.
    Ann Nucl Med. 2024 Mar 27. doi: 10.1007/s12149-024-01921.
    >> Share

  280. FUKAI S, Daisaki H, Umeda T, Shimada N, et al
    Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment.
    Ann Nucl Med. 2024 Mar 22. doi: 10.1007/s12149-024-01918.
    >> Share

  281. SHANG C, Sakurai K, Nihashi T, Arahata Y, et al
    Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods.
    Ann Nucl Med. 2024 Mar 21. doi: 10.1007/s12149-024-01919.
    >> Share

  282. LEE K, Han S, Ryu J, Cho SG, et al
    Prognostic value of left ventricular mechanical dyssynchrony indices derived from gated myocardial perfusion SPECT in coronary artery disease: a systematic review and meta-analysis.
    Ann Nucl Med. 2024 Mar 18. doi: 10.1007/s12149-024-01915.
    >> Share

  283. MARUO A, Magota K, Munakata Y, Hirata K, et al
    Improvement in the estimation of perfusable tissue fraction and myocardial flow reserve in the ischemic myocardial lesions using ECG-gated dynamic myocardial PET with (15)O-water.
    Ann Nucl Med. 2024 Mar 13. doi: 10.1007/s12149-024-01913.
    >> Share

  284. ZHANG X, Nakajima K, Mizokami A, Horikoshi H, et al
    Flare phenomenon visualized by (99m)Tc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer.
    Ann Nucl Med. 2024 Mar 13. doi: 10.1007/s12149-024-01914.
    >> Share

  285. WAGATSUMA K, Ikemoto K, Inaji M, Kamitaka Y, et al
    Impact of [(11)C]methionine PET with Bayesian penalized likelihood reconstruction on glioma grades based on new WHO 2021 classification.
    Ann Nucl Med. 2024 Mar 11. doi: 10.1007/s12149-024-01911.
    >> Share

  286. MIYAMOTO M, Okuyama C, Kagawa S, Kusano K, et al
    Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
    Ann Nucl Med. 2024 Mar 7. doi: 10.1007/s12149-024-01917.
    >> Share

  287. OZUTEMIZ C, Koksel Y, Froelich JW, Rubin N, et al
    The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and its relationship with myocardial suppression.
    Ann Nucl Med. 2024 Mar 2. doi: 10.1007/s12149-024-01910.
    >> Share

  288. NOIPINIT N, Sukprakun C, Siricharoen P, Khamwan K, et al
    Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing (99m)Tc-MAA and (90)Y-microspheres radioembolization.
    Ann Nucl Med. 2024;38:210-218.
    >> Share

    February 2024
  289. OKIZAKI A, Nishiyama Y, Inui Y, Otsuka H, et al
    Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022.
    Ann Nucl Med. 2024 Feb 29. doi: 10.1007/s12149-024-01905.
    >> Share

  290. KANEKO K, Nagao M, Ueda K, Yamamoto A, et al
    Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor (11)C-methionine PET/CT imaging.
    Ann Nucl Med. 2024 Feb 22. doi: 10.1007/s12149-024-01908.
    >> Share

  291. HONG Z, Xu H, Ni K, Yang Y, et al
    Effect of Cyclosporin H on ischemic injury and neutrophil infiltration in cerebral infarct model of rats via PET imaging.
    Ann Nucl Med. 2024 Feb 15. doi: 10.1007/s12149-024-01900.
    >> Share

  292. NIITSU H, Fukumitsu N, Tanaka K, Mizumoto M, et al
    Methyl-(11)C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma.
    Ann Nucl Med. 2024 Feb 14. doi: 10.1007/s12149-024-01901.
    >> Share

  293. AMIRI A, Fazaeli Y, Zare H, Eslami-Kalantari M, et al
    Radiolabeled florescent-magnetic graphene oxide nanosheets: probing the biodistribution of a potential PET-MRI hybrid imaging agent for detection of fibrosarcoma tumor.
    Ann Nucl Med. 2024 Feb 12. doi: 10.1007/s12149-024-01902.
    >> Share

  294. SINGHAL T, Singh P, Parida GK, Agrawal K, et al
    Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
    Ann Nucl Med. 2024 Feb 10. doi: 10.1007/s12149-024-01904.
    >> Share

  295. MARUYAMA H, Gomi M, Lwin TT, Yoneyama A, et al
    [(18)F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer's disease using a dynamic autoradiography technique.
    Ann Nucl Med. 2024;38:120-130.
    >> Share

    January 2024
  296. TAMURA K, Nishii R, Tani K, Hashimoto H, et al
    A first-in-man study of [(18)F] FEDAC: a novel PET tracer for the 18-kDa translocator protein.
    Ann Nucl Med. 2024 Jan 29. doi: 10.1007/s12149-023-01895.
    >> Share

  297. SINGH SB, Bhandari S, Bhandari S, Bhandari S, et al
    Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.
    Ann Nucl Med. 2024 Jan 26. doi: 10.1007/s12149-023-01896.
    >> Share

  298. HOTTA M, Sonni I, Thin P, Nguyen K, et al
    Visual and whole-body quantitative analyses of (68) Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with (177)Lu-DOTATATE.
    Ann Nucl Med. 2024 Jan 22. doi: 10.1007/s12149-023-01899.
    >> Share

  299. DERAKHSHAN S, Ghaderi B, Roshani D
    Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI.
    Ann Nucl Med. 2024 Jan 20. doi: 10.1007/s12149-023-01897.
    >> Share

  300. AN R, Ma X, Wang Y
    The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
    Ann Nucl Med. 2024 Jan 13. doi: 10.1007/s12149-023-01892.
    >> Share

  301. LI T, Dou J, Zhang H, Su X, et al
    Optimized gated a SPECT-derived myocardial salvage index: its prognostic significance in predicting major adverse cardiac events following acute myocardial infarction percussion.
    Ann Nucl Med. 2024 Jan 4. doi: 10.1007/s12149-023-01894.
    >> Share

  302. TAMAKI N, Manabe O
    Current status and perspectives of nuclear cardiology.
    Ann Nucl Med. 2024;38:20-30.
    >> Share

  303. NAKAJIMA K, Miyauchi H, Hirano KI, Fujimoto S, et al
    Practice recommendation for measuring washout rates in (123)I-BMIPP fatty acid images.
    Ann Nucl Med. 2024;38:1-8.
    >> Share

    December 2023
  304. KAWAKUBO M, Nagao M, Kaimoto Y, Nakao R, et al
    Deep learning approach using SPECT-to-PET translation for attenuation correction in CT-less myocardial perfusion SPECT imaging.
    Ann Nucl Med. 2023 Dec 28. doi: 10.1007/s12149-023-01889.
    >> Share

  305. LIN JT, Li XM, Zhong WZ, Hou QY, et al
    Impact of preoperative [(18)F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.
    Ann Nucl Med. 2023 Dec 25. doi: 10.1007/s12149-023-01888.
    >> Share

  306. CUI FB, Lv X, Yan CL, Eng WS, et al
    Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis.
    Ann Nucl Med. 2023 Dec 25. doi: 10.1007/s12149-023-01893.
    >> Share

    November 2023
  307. PACELLA S, Grappeja L
    Prognostic value of pre-treatment 18F-FDG PET/CT parameters in endometrial cancer.
    Ann Nucl Med. 2023 Nov 27. doi: 10.1007/s12149-023-01887.
    >> Share

  308. SHINOHARA Y, Ibaraki M, Matsubara K, Sato K, et al
    Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner.
    Ann Nucl Med. 2023 Nov 21. doi: 10.1007/s12149-023-01886.
    >> Share

  309. SANAAT A, Amini M, Arabi H, Zaidi H, et al
    The quest for multifunctional and dedicated PET instrumentation with irregular geometries.
    Ann Nucl Med. 2023 Nov 12. doi: 10.1007/s12149-023-01881.
    >> Share

  310. PERERA MOLLIGODA ARACHCHIGE AS
    Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight.
    Ann Nucl Med. 2023 Nov 9. doi: 10.1007/s12149-023-01882.
    >> Share

  311. WATANABE S, Hirata K, Magota K, Takenaka J, et al
    Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET.
    Ann Nucl Med. 2023 Nov 9. doi: 10.1007/s12149-023-01884.
    >> Share

  312. SHAMIM SA, Kumar N, Arora G, Jaswal S, et al
    A prospective study of (68)Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential (177)Lu-PSMA therapy.
    Ann Nucl Med. 2023 Nov 6. doi: 10.1007/s12149-023-01876.
    >> Share

  313. CUI N, Li J, Jiang Z, Long Z, et al
    Development and validation of (18)F-FDG PET/CT radiomics-based nomogram to predict visceral pleural invasion in solid lung adenocarcinoma.
    Ann Nucl Med. 2023;37:605-617.
    >> Share

    October 2023
  314. MICHALSKI K, Kosmala A, Werner RA, Serfling SE, et al
    Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy.
    Ann Nucl Med. 2023 Oct 27. doi: 10.1007/s12149-023-01874.
    >> Share

  315. NAKAMOTO Y, Baba S, Kaida H, Manabe O, et al
    Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects.
    Ann Nucl Med. 2023 Oct 20. doi: 10.1007/s12149-023-01873.
    >> Share

  316. MAKINO A, Kume K, Mori T, Tsujikawa T, et al
    High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography.
    Ann Nucl Med. 2023 Oct 19. doi: 10.1007/s12149-023-01877.
    >> Share

  317. NITTA N, Yoshimatsu R, Iwasa H, Nakaji K, et al
    Difference in arterial FDG accumulation in healthy study participants between digital PET/CT and standard PET/CT.
    Ann Nucl Med. 2023 Oct 18. doi: 10.1007/s12149-023-01875.
    >> Share

  318. MIYAJI N, Miwa K, Yamashita K, Motegi K, et al
    Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm.
    Ann Nucl Med. 2023 Oct 5. doi: 10.1007/s12149-023-01870.
    >> Share

  319. LIU C, Ma G, Zhang J, Cheng J, et al
    (18)F-FES and (18)F-FDG PET/CT imaging as a predictive biomarkers for metastatic breast cancer patients undergoing cyclin-dependent 4/6 kinase inhibitors with endocrine treatment.
    Ann Nucl Med. 2023 Oct 3. doi: 10.1007/s12149-023-01871.
    >> Share

  320. GUNER LA, Unal K, Beylergil V, Tuna MB, et al
    Enhancing PSMA PET/CT imaging of prostate cancer: investigating the impact of multiple time point evaluation, diuretic administration, cribriform pattern, and intraductal carcinoma.
    Ann Nucl Med. 2023 Oct 3. doi: 10.1007/s12149-023-01864.
    >> Share

    September 2023
  321. SADEGHI MH, Sina S, Alavi M, Giammarile F, et al
    The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [(18)F]FDG PET/CT examinations.
    Ann Nucl Med. 2023 Sep 28. doi: 10.1007/s12149-023-01867.
    >> Share

  322. KIDERA E, Koyasu S, Hirata K, Hamaji M, et al
    Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using (18)F-FDG PET.
    Ann Nucl Med. 2023 Sep 27. doi: 10.1007/s12149-023-01866.
    >> Share

  323. HIRATA K, Kamagata K, Ueda D, Yanagawa M, et al
    From FDG and beyond: the evolving potential of nuclear medicine.
    Ann Nucl Med. 2023 Sep 25. doi: 10.1007/s12149-023-01865.
    >> Share

  324. SUN X, Yao X, Zeng B, Zhu L, et al
    Association of mismatch repair deficiency in endometrial cancer with (18)F-FDG PET/CT and clinicopathological features and their prognostic value.
    Ann Nucl Med. 2023 Sep 24. doi: 10.1007/s12149-023-01869.
    >> Share

  325. LIU Z, Daniels T, Campen MJ, Alvidrez RIM, et al
    Inflammatory atherosclerotic plaque identification by SPECT/CT imaging of LFA-1 using [(111)In] In-DANBIRT in a novel dyslipidemic rat model.
    Ann Nucl Med. 2023 Sep 24. doi: 10.1007/s12149-023-01868.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016